Cytospire Therapeutics is a UK-based biotech developing differentiated multispecific immune cell engager antibodies designed to enhance and direct the activity of the body’s own immune system, focusing on next generation γδ T cell engagers for cancer therapies
Cytospire Therapeutics is a UK-based biotech developing differentiated multispecific immune cell engager antibodies designed to enhance and direct the activity of the body’s own immune system, focusing on next generation γδ T cell engagers for cancer therapies.